Literature DB >> 20309922

Race, ethnicity, ancestry, and pharmacogenetics.

Thomas J Urban1.   

Abstract

Pharmacogenetics is the study of how genetic variation influences the response to drugs. The concepts of race, ethnicity, and ancestry have long had a strong influence on pharmacogenetic discovery and on our understanding of population-level differences in drug response. The primary goal of pharmacogenetics, however, is to identify the individual genetic determinants of drug activity so that therapy can be tailored to the individual patient. This article describes the relationship between the concepts of race, ethnicity, and ancestry and how these concepts have been applied to pharmacogenetics, and it provides examples of the benefits and pitfalls associated with the use of racial or ethnic labels in genetic studies. The future of pharmacogenetics, including the study of rare genetic variation and what this means for racial or ethnic disparities in pharmacogenetic discovery, is also discussed. (c) 2010 Mount Sinai School of Medicine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20309922     DOI: 10.1002/msj.20168

Source DB:  PubMed          Journal:  Mt Sinai J Med        ISSN: 0027-2507


  11 in total

1.  Standardized Biogeographic Grouping System for Annotating Populations in Pharmacogenetic Research.

Authors:  Rachel Huddart; Alison E Fohner; Michelle Whirl-Carrillo; Genevieve L Wojcik; Christopher R Gignoux; Alice B Popejoy; Carlos D Bustamante; Russ B Altman; Teri E Klein
Journal:  Clin Pharmacol Ther       Date:  2019-01-21       Impact factor: 6.875

Review 2.  Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting.

Authors:  L V Kalman; Jag Agúndez; M Lindqvist Appell; J L Black; G C Bell; S Boukouvala; C Bruckner; E Bruford; K Caudle; S A Coulthard; A K Daly; Al Del Tredici; J T den Dunnen; K Drozda; R E Everts; D Flockhart; R R Freimuth; A Gaedigk; H Hachad; T Hartshorne; M Ingelman-Sundberg; T E Klein; V M Lauschke; D R Maglott; H L McLeod; G A McMillin; U A Meyer; D J Müller; D A Nickerson; W S Oetting; M Pacanowski; V M Pratt; M V Relling; A Roberts; W S Rubinstein; K Sangkuhl; M Schwab; S A Scott; S C Sim; R K Thirumaran; L H Toji; R F Tyndale; Rhn van Schaik; M Whirl-Carrillo; Ktj Yeo; U M Zanger
Journal:  Clin Pharmacol Ther       Date:  2015-11-20       Impact factor: 6.875

3.  Minimum information required for a DMET experiment reporting.

Authors:  Judit Kumuthini; Mamana Mbiyavanga; Emile R Chimusa; Jyotishman Pathak; Panu Somervuo; Ron Hn Van Schaik; Vita Dolzan; Clint Mizzi; Kusha Kalideen; Raj S Ramesar; Milan Macek; George P Patrinos; Alessio Squassina
Journal:  Pharmacogenomics       Date:  2016-08-22       Impact factor: 2.533

Review 4.  Pharmacogenetics of nicotine addiction: role of dopamine.

Authors:  Aryeh I Herman; Elise E DeVito; Kevin P Jensen; Mehmet Sofuoglu
Journal:  Pharmacogenomics       Date:  2014-02       Impact factor: 2.533

5.  Randomized clinical trial comparing the pharmacokinetics of standard- and increased-dosage lopinavir-ritonavir coformulation tablets in HIV-positive pregnant women.

Authors:  Marilia Santini-Oliveira; Rita de Cássia Elias Estrela; Valdiléa Gonçalves Veloso; Vitória Berg Cattani; Carolyn Yanavich; Luciane Velasque; Thiago Silva Torres; Luana Monteiro Spindola Marins; José Henrique Pilotto; Esaú Custódio João; José Carlos Saraiva Gonçalves; Beatriz Grinsztejn
Journal:  Antimicrob Agents Chemother       Date:  2014-03-10       Impact factor: 5.191

6.  The pharmacoepigenomics informatics pipeline defines a pathway of novel and known warfarin pharmacogenomics variants.

Authors:  Ari Allyn-Feuer; Alex Ade; Jasmine A Luzum; Gerald A Higgins; Brian D Athey
Journal:  Pharmacogenomics       Date:  2018-02-05       Impact factor: 2.533

7.  Survival differences by race/ethnicity among children and adolescents diagnosed with germ cell tumors.

Authors:  Lindsay A Williams; A Lindsay Frazier; Jenny N Poynter
Journal:  Int J Cancer       Date:  2019-07-31       Impact factor: 7.396

Review 8.  Reporting results in U.S. clinical trials for obstructive sleep apnea and insomnia: How transparent are they?

Authors:  Zhe He; Douglas M Wallace; Andrea Barnes; Xiang Tang; Girardin Jean-Louis; Natasha J Williams
Journal:  Sleep Health       Date:  2020-03-14

9.  Genetic background of patients from a university medical center in Manhattan: implications for personalized medicine.

Authors:  Bamidele O Tayo; Marie Teil; Liping Tong; Huaizhen Qin; Gregory Khitrov; Weijia Zhang; Quinbin Song; Omri Gottesman; Xiaofeng Zhu; Alexandre C Pereira; Richard S Cooper; Erwin P Bottinger
Journal:  PLoS One       Date:  2011-05-04       Impact factor: 3.240

10.  Pharmacogenomics, human genetic diversity and the incorporation and rejection of color/race in Brazil.

Authors:  Ricardo Ventura Santos; Gláucia Oliveira da Silva; Sahra Gibbon
Journal:  Biosocieties       Date:  2015-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.